论文部分内容阅读
大量观察已经确证虹膜“黑色素瘤”的预后是良好的。本文对189例虹膜或虹膜睫状体肿瘤的临床病理分析结果支持已经发表的材料;但作者等对病理的理解有所不同。作者认为一律保留虹膜“黑色素瘤”的名称,已经妨碍了认识这种病变大多数在实际上是良性、“进行性”的痣。他们建议采用新的分类方法。分析哈克奈斯眼科研究所的189例虹膜黑色素瘤,此中103例病变全部位于虹膜内,其余86例同时波及睫状体,但病变的50%以上是在虹膜内。追随观察138例(73%),平均随访11年。根据病理特征,作者等将189例病人归为以下9类: 第1类黑色素细胞增多症:病变由色素多
Extensive observation has confirmed that the prognosis of iris “melanoma” is good. The clinical and pathological analysis of 189 cases of iris or iris ciliary body tumors supports the published material; however, the authors differ in their understanding of the pathology. The authors believe that retaining the iris “melanoma” name altogether has prevented the understanding that the majority of the lesions are in fact benign, “progressive” moles. They suggest a new classification method. Analysis of 189 cases of iris melanoma Harkness Institute of ophthalmology, of which 103 cases were all located in the iris lesions, the remaining 86 cases also affect the ciliary body, but more than 50% of lesions in the iris. Follow-up observation of 138 cases (73%), with an average follow-up of 11 years. According to the pathological features, the authors classify 189 patients into the following 9 categories: Category 1 melanocytosis: lesions are pigmented